AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 14 filers reported holding AKARI THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $22,774 | +48355.3% | 134,046 | -48.7% | 0.00% | – |
Q1 2023 | $47 | +74.1% | 261,192 | +374.2% | 0.00% | – |
Q4 2022 | $27 | -99.9% | 55,081 | +46.7% | 0.00% | – |
Q3 2022 | $24,000 | +71.4% | 37,544 | +162.9% | 0.00% | – |
Q2 2022 | $14,000 | -44.0% | 14,281 | -6.5% | 0.00% | – |
Q3 2021 | $25,000 | -57.6% | 15,276 | -43.6% | 0.00% | – |
Q2 2020 | $59,000 | +37.2% | 27,097 | -1.1% | 0.00% | – |
Q4 2018 | $43,000 | -38.6% | 27,409 | +0.4% | 0.00% | – |
Q3 2018 | $70,000 | +1.4% | 27,296 | -22.8% | 0.00% | – |
Q2 2018 | $69,000 | -77.8% | 35,343 | -79.3% | 0.00% | – |
Q1 2018 | $311,000 | -72.4% | 170,622 | -34.4% | 0.00% | -100.0% |
Q4 2017 | $1,126,000 | +58.8% | 260,020 | +125.0% | 0.00% | +100.0% |
Q3 2017 | $709,000 | -28.2% | 115,543 | -46.0% | 0.00% | -50.0% |
Q2 2017 | $987,000 | +32.8% | 214,126 | +318.0% | 0.00% | 0.0% |
Q4 2015 | $743,000 | -50.0% | 51,221 | -17.3% | 0.00% | -33.3% |
Q3 2015 | $1,486,000 | – | 61,942 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VHCP Management II, LLC | 426,297 | $1,965,000 | 0.78% |
Vivo Capital, LLC | 527,842 | $2,433,000 | 0.61% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 818,158 | $3,772,000 | 0.20% |
NEA Management Company, LLC | 452,167 | $2,084,000 | 0.08% |
Hikari Power Ltd | 60,012 | $277,000 | 0.04% |
Baker Brothers Advisors | 496,901 | $2,291,000 | 0.02% |
QVT Financial LP | 132,077 | $531,000 | 0.01% |
MILLENNIUM MANAGEMENT LLC | 214,126 | $987,000 | 0.00% |
Virtu KCG Holdings LLC | 12,472 | $57,000 | 0.00% |
Advisor Group, Inc. | 6,381 | $29,000 | 0.00% |